Recall of Advair Diskus announced October 15, 2004
On October 15, 2004, GSK issued a voluntary lot recall of Advair Diskus 100/50. This lot recall was issued due to a defect that in some circumstances could mean that patients would not receive their asthma maintenance medicine. Patients should not discontinue use of Advair, but should check the lot numbers and get replacements of any products in these particular lots. Other strengths or pack sizes of Advair Diskus are not affected, and products outside the United States are not affected. The affected lot numbers are as follows: 4ZP2067, 4ZP2619, 4ZP3244, 4ZP2104, 4ZP2759, 4ZP3272, 4ZP2201, 4ZP2807, 4ZP3373, 4ZP2216, 4ZP2913, 4ZP3444, 4ZP2217, 4ZP2901, 4ZP3504, 4ZP2229, 4ZP3041, 4ZP3550, 4ZP2377, 4ZP3042, 4ZP3631, 4ZP2474, 4ZP3139, 4ZP3659, 4ZP2475 Other lots of these products are not affected. The lot number of each inhaler is printed on the circular label in the center of the Diskus. The lot number also appears on the foil overwrap and on the box. Patients who identify an inhaler from any of these lots should return it to the pharmacy they purchased the prescription from. If you obtained your prescription through your mail service pharmacy, please contact the Customer Service team at the 800 number provided on your identification card. Please note: The majority of the inhalers from these lots work in the normal way, and patients should continue to use their inhalers until they are able to exchange them. For additional information please visit the GlaxoSmithKline Web site at: http://www.gsk.com/index.htm
Our reviewers are members of Consumer Health Interactive's medical advisory board.
To learn more about our writers and editors, click here.
Last updated September 18, 2009
|
